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LETTER TO THE  EDITOR
Reply to  Letter to  the Editor by
Griffiths et  al. commenting on
Evans  & Allen
Respuesta a la  carta al  editor de Griffiths
et al.,  como comentario al documento  de
Evans &  Allen
We  are  grateful  to  Griffiths  & co-authors  for their  inter-
est  in  our  systematic  review.1 The  review  was  intended  to
stimulate  debate  and  encourage  further  research  in this con-
troversial  area.  In the opening  paragraph  of  the paper  we
note  that  a  review  in  this field  is  challenging  because  of the
lack  of  large randomised  controlled  trials  (RCTs)  and that  a
similar  situation  in  a  different  field  led  Joyce  et  al.  to  adopt
a  pragmatic  approach  to  a systematic  review2 and that we
decided  to  follow  a  similar  approach.
Griffiths  et  al.  refer  to  ‘‘the  CASP  checklist’’,  but  in
fact  there  are  eight  CASP  critical  appraisal  tools for  dif-
ferent  types  of  study.3 These  include  CASP  checklists  for
randomised  controlled  trials,  case  control  trials,  and  cohort
studies  and  so  were  well  suited  to  our  task  of  reviewing  a
heterogeneous  literature.
We now  turn  to  the specific  issue  that  Griffiths  et al.
raise  concerning  the CASP  checklist  for  RCTs.  This  checklist
includes  11  main  questions,  most of  which have  sub-
questions  giving  a  total  of  23  items.  To  include  a table  with
columns  for  each  of  these  items,  in  addition  to  columns
identifying  the study  authors  and  study  design,  would  not
have  been  practical.  The  three  questions  posed  by  Griffiths
et  al.  were  considered  in our  review.  The  question  ‘‘Can
the  results  be  applied  in your  context?’’  was  considered  in
Column  3  (‘‘Population  appropriate?’’)  of Table  2 and  Table
3.  The  question  ‘‘Were  all  clinically  important  outcomes
considered?’’  was  included  in Column  6  (‘‘Outcomes  appro-
priate?’’)  in  both  tables.  The  question  ‘‘Were  the benefits
worth  the  harms  and  costs’’  can  be  taken  generically  in this
subject  because  the benefits  from  coloured  filters  in  visual
stress  are  simply  reduced  symptoms  and/or  an improvement
in  reading  fluency.  This  is  stated  in the  last paragraph  of  the
DOI of original article:
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Discussion,  which  notes  the  safe  nature  of  the  intervention.
Nonetheless,  the  penultimate  paragraph  of  the Discussion
raises  possible  harms  or  costs,  explicitly  considering  psycho-
logical  effects  of  coloured  filters  and  possible  costs  to the
patient  and  family  in terms  of expense,  time,  and  raised
expectations.  We  did not use  exactly  the  same  wording  as
CASP  but  instead  used  wording  appropriate  to  the topic
under  review.
Griffiths  et  al.’s  claim  that  the different  headings  of  Table
2  and Table  3  represent  ‘‘cherry-picking’’  is  incorrect.  The
caption  to  Table  2 clearly  states  that  Table  2 excluded  ‘‘two
CASP  criteria:  masking  (it  is  not possible  to  double  mask
overlay  studies)  and it  is  assumed  that  groups  were  treated
equally  as  all studies  are repeated  measures  trials’’.  In other
respects  the domains  listed  in both  tables  are the same.  Con-
trary  to  Griffiths  et  al.’s  assertion,  different  studies  were
not  assessed  according  to  different  criteria,  but  rather  the
over-riding  limitation  of lack  of  masking  in overlay  studies
was  highlighted  in  the heading  to  the  relevant  table.  This
is  highlighted  again  in the relevant  section  of  the Results
where  we  say ‘‘It  is  not possible  to mask  participants  in
a  trial  comparing  coloured  overlays  with  a control  (e.g.,
grey),  and  this  represents  a  risk  of  bias  across  studies’’.
The  issue  of  controlling  for the placebo  effect  is  returned  to
once  again  in the  Discussion.  In  Table  3  the  column  entitled
‘‘Masked?’’  does  identify  studies  that  were  double-masked,
single-masked  (none), uncertain,  or  with  no masking.  We
therefore  reject  Griffiths  et al.’s  claim  that  we  developed
our  own  ‘‘hybrid  RoB  rating  scale’’.
Clearly,  in a  review  by  two  authors  it was  not possible  to
refer  disagreements  to  a third  party.  Our approach  in  such
cases was  to  discuss  disagreements  to  reach  consensus  and
this  was  achieved  in every  case.  The  only exception  to  this
was  sections  of the review  relating  to  the work  of  one  of  the
review  authors  in  which case  the views  of  the  other  reviewer
took  precedence.
Griffiths  et al. cite their  own  review,4 which  they  describe
as  more  wide-ranging.  In  our  opinion  this  review  does  not
consider  what  is  perhaps  the  most  important  risk  of  bias:
whether  the studies  under  review  investigate  the target
condition.  Their  review  includes  studies  of  quite  small
populations  of  people  solely  selected  as  having  dyslexia  or
reading  difficulties.  Yet,  coloured  filters  are  not  considered
as  a treatment  for dyslexia,  but  rather  for  visual  stress,  and
most people with  dyslexia  do  not have  visual  stress.1 We  con-
sider  that  this,  and other  limitations  of  that review,5,6 mean
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that  it  was  destined  from  the  outset  to  support  a  negative
stance.
Griffiths  et  al. ask  how  our  review  concludes  that  the
balance  of  evidence  suggests  that coloured  filters  can allevi-
ate  symptoms  or  improve  performance  in people  who  suffer
from  visual  stress.  There  are  three  main  sections  of  our
Results.  The  first  reviews  10  trials  with  Intuitive  Overlays
which  all  found  statistically  significant  improvements  in per-
formance  with  individually  selected  overlays.  In  the review
and  again  now  we  caution  about  risk  of  bias  in  this result
because  it  is not possible  to  mask  participants  in trials  with
overlays.  In  the second  section  we  review  three  papers  that
each  describes  large programmes  of  research  in  which sev-
eral  studies  combine  to  address  many  of the  limitations  of
overlay  studies.  We  think  that  the  findings  of  these  studies
add  some  weight  to  the hypothesis  that  overlays  improve
performance  for reasons  that  are not  solely  attributable  to
placebo  and  Hawthorne  effects.  The  third  section  reviews
trials  using  the  Intuitive  Colorimeter  and  Precision  Tinted
Lenses  and  all  studies  found  significant  improvement  of
symptoms  or  performance  from  colour  prescribed  with  the
Intuitive  Colorimeter.  Our  review  highlights  limitations  of
these  studies  and we  agree  with  Griffiths  et al. that  there  is
more  to  a  systematic  review  than  just counting  up  the num-
ber  of  positive  studies.  This  is  why, despite  the large  number
of  studies  with  positive  results,  we used  modest  language  in
concluding  that  ‘‘the  balance  of evidence  suggests’’  that
coloured  filters  are  helpful  in individuals  with  visual  stress.
We  are  puzzled  as  to  why the  review  of  Griffiths  and
co-authors  makes  no  mention  of  the fact that  over  80%
of  studies  in their Table 2 using  the ‘‘Intuitive  system’’
found  statistically  significant  positive  results.  We  accept
that  such  a  count  is  not  proof  of  effectiveness,  but  nei-
ther  is  it  irrelevant.  At  the least,  such  widespread  positive
results  are  consistent  with  the fact that  these  interventions
remain  popular  and  the limitations  of  this  research  explain
why  the  interventions  remain controversial  and  this issue
unresolved.
We accept  the  very  constructive  point that  Griffiths  et  al.
make  in  their  last paragraph  and  we  agree  that there  are
several  areas  on  which  we  agree  and  these  are more  impor-
tant  than  those  on  which we differ.  We  would  also  highlight
some  additional  areas  on  which  we  believe  that  there  is
agreement  in  our  position  and  that of  Griffiths  et  al.  Before
coloured  lenses  are prescribed  it  is  important  to  rule  out
conventional  optometric  causes  of a  child’s  symptoms.  Only
a  minority  of  dyslexic  children  have  visual anomalies  and
when  a  visual  problem  is found  the  optometrist  should  not
claim  to  be  treating  dyslexia.  However,  we  believe  that
visual  problems,  including  visual  stress,  can  co-occur  with
dyslexia  and  in some  cases  contribute  to  reading  difficulties.
We  believe  that  children  who  struggle  with  reading  should
have  an  eye  examination  and  their  eyecare  practitioners
should  ask  about  symptoms,  including  words  blurring  and
moving.  For the  minority  of  children  who  have  these  symp-
toms  the optometrist  may  be able  to  alleviate  a  visual
barrier  to the child  benefiting  from  the  specialist  educa-
tional  interventions  that  they will  be  likely  to need.
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